•
OA
OABI
OmniAb, Inc. Common Stock
yahooSERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
--
Price Chart
Market Cap
289.35M
Volume
500.09K
52W High
$4.02
52W Low
$1.22
Open
$0.00
Prev Close
$1.90
Day Range
0.00 - 0.00
About OmniAb, Inc. Common Stock
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
Latest News
AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway
Benzinga•Jun 30
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
GlobeNewswire Inc.•May 5
USANA Health Sciences (USNA) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research•Apr 30
Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying
Benzinga•Mar 26
Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research•Mar 5
Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research•Feb 29
OmniAb, Inc. (OABI) Soars 10.5%: Is Further Upside Left in the Stock?
Zacks Investment Research•Feb 28
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research•Feb 27